GGrantIndex
← Leaderboards

Judy L. Bolton

University Of Illinois At Chicago

$10,491,560
Attributed
$10,491,560
Total exposure
10
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $779.3K · FY200519
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$10,491,560 · 10

By mechanism

R01$5,838,987 · 3
P50$4,316,343 · 4
R56$215,930 · 1
R29$107,400 · 1
R13$12,900 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Illinois At Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Dna Damage

Research focus

Dna DamageEstrogensEstrogen ReceptorsQuinonesCellsWomen&AposS HealthCarcinogenesisAlkylationPharmaceutical PreparationsRattusEnzymesReportingWomanOxidationIn VivoLinkCell LineLuciferasesHormonesBreastResearch StudyCell TransformationCatechols

Grant awards (47)

Van Breemen: Project 2; Botanicals Affect Resilience Through Modulation of Estrogen Carcinogenic Pathways (Bolton)$357,663
P50 · FY2019 · AT · contact PI
Van Breemen: Core 2; Bioassay Core (Bolton)$228,476
P50 · FY2019 · AT · contact PI
Van Breemen: Project 2; Botanicals Affect Resilience Through Modulation of Estrogen Carcinogenic Pathways (Bolton)$335,264
P50 · FY2018 · AT · contact PI
Van Breemen: Core 2; Bioassay Core (Bolton)$215,104
P50 · FY2018 · AT · contact PI
Van Breemen: Project 2; Botanicals Affect Resilience Through Modulation of Estrogen Carcinogenic Pathways (Bolton)$343,877
P50 · FY2017 · AT · contact PI
Van Breemen: Core 2; Bioassay Core (Bolton)$219,202
P50 · FY2017 · AT · contact PI
Van Breemen: Project 2; Botanicals Affect Resilience Through Modulation of Estrogen Carcinogenic Pathways (Bolton)$344,232
P50 · FY2016 · AT · contact PI
Van Breemen: Core 2; Bioassay Core (Bolton)$227,872
P50 · FY2016 · AT · contact PI
Van Breemen: Project 2; Botanicals Affect Resilience Through Modulation of Estrogen Carcinogenic Pathways (Bolton)$366,473
P50 · FY2015 · AT · contact PI
Van Breemen: Core 2; Bioassay Core (Bolton)$233,786
P50 · FY2015 · AT · contact PI
Carcinogenic Metabolites Formed from Antiestrogen$209,632
R01 · FY2013 · CA · contact PI
Carcinogenic Metabolites Formed from Antiestrogen$223,012
R01 · FY2012 · CA · contact PI
Role of electrophilic/redox active quinoids in estrogen carcinogenesis$282,625
R01 · FY2011 · CA · contact PI
Carcinogenic Metabolites Formed from Antiestrogen$223,012
R01 · FY2011 · CA · contact PI
Role of electrophilic/redox active quinoids in estrogen carcinogenesis$291,366
R01 · FY2010 · CA · contact PI
Carcinogenic Metabolites Formed from Antiestrogen$229,909
R01 · FY2010 · CA · contact PI
Role of electrophilic/redox active quinoids in estrogen carcinogenesis$291,366
R01 · FY2009 · CA · contact PI
MECHANISMS OF ACTION IN MENOPAUSE$257,986
P50 · FY2009 · AT · contact PI
Carcinogenic Metabolites Formed from Antiestrogen$229,909
R01 · FY2009 · CA · contact PI
Role of electrophilic/redox active quinoids in estrogen carcinogenesis$291,366
R01 · FY2008 · CA · contact PI
MECHANISMS OF ACTION IN MENOPAUSE$256,716
P50 · FY2008 · AT · contact PI
Carcinogenic Metabolites Formed from Antiestrogens$215,930
R56 · FY2008 · CA · contact PI
Role of electrophilic/redox active quinoids in estrogen carcinogenesis$291,366
R01 · FY2007 · CA · contact PI
MECHANISMS OF ACTION IN MENOPAUSE$263,047
P50 · FY2007 · AT · contact PI
Carcinogenic Metabolites formed from Antiestrogens$215,930
R01 · FY2007 · CA · contact PI
Carcinogenic Metabolites formed from Antiestrogens$222,552
R01 · FY2006 · CA · contact PI
MECHANISMS OF ACTION IN MENOPAUSE$213,701
P50 · FY2006 · AT · contact PI
Biotransformation of Estrogens to Carcinogenic Quinoids$304,031
R01 · FY2005 · CA
Carcinogenic Metabolites formed from Antiestrogens$228,079
R01 · FY2005 · CA
MECHANISMS OF ACTION IN MENOPAUSE$204,529
P50 · FY2005 · AT
Biotransformation of Estrogens to Carcinogenic Quinoids$304,031
R01 · FY2004 · CA
Carcinogenic Metabolites formed from Antiestrogens$228,246
R01 · FY2004 · CA
Biotransformation of Estrogens to Carcinogenic Quinoids$304,031
R01 · FY2003 · CA
Carcinogenic Metabolites formed from Antiestrogens$271,095
R01 · FY2003 · CA
Biotransformation of Estrogens to Carcinogenic Quinoids$304,031
R01 · FY2002 · CA
CARCINOGENIC METABOLITES FORMED FROM ANTIESTROGENS$197,496
R01 · FY2002 · CA
Estrogenic Agents--In Vitro and In Vivo Evaluation$0
P50 · FY2002 · AT
Estrogenic Agents--In Vitro and In Vivo Evaluation$0
P50 · FY2002 · AT
Biotransformation of Estrogens to Carcinogenic Quinoids$317,999
R01 · FY2001 · CA
CARCINOGENIC METABOLITES FORMED FROM ANTIESTROGENS$191,744
R01 · FY2001 · CA
Symposium on Mechanisms of estrogen carcinogenesis$12,900
R13 · FY2001 · CA
Estrogenic Agents--In Vitro and In Vivo Evaluation$0
P50 · FY2001 · AT
Estrogenic Agents--In Vitro and In Vivo Evaluation$0
P50 · FY2001 · AT
Estrogenic Agents--In Vitro and In Vivo Evaluation$0
P50 · FY2001 · AT
Estrogenic Agents--In Vitro and In Vivo Evaluation$248,415
P50 · FY2000 · AT
CARCINOGENIC METABOLITES FORMED FROM ANTIESTROGENS$186,159
R01 · FY2000 · CA
BIOTRANSFORMATION OF ESTROGEN TO CARCINOGENIC QUINOIDS$107,400
R29 · FY2000 · CA